NDT Pharmaceuticals Inc
NDT Pharmaceuticals Inc., a biotechnology company, focuses on developing various therapies for severe neurological disorders associated with traumatic brain Injury. The company is based in Vienna, Virginia.
NDT Pharmaceuticals Inc (NDTP) - Net Assets
Latest net assets as of : $- USD
Based on the latest financial reports, NDT Pharmaceuticals Inc (NDTP) has net assets worth $- USD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
NDT Pharmaceuticals Inc - Net Assets Trend (None–None)
This chart illustrates how NDT Pharmaceuticals Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for NDT Pharmaceuticals Inc (None–None)
The table below shows the annual net assets of NDT Pharmaceuticals Inc from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to NDT Pharmaceuticals Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
NDT Pharmaceuticals Inc Competitors by Market Cap
The table below lists competitors of NDT Pharmaceuticals Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Meezan Pakistan
KAR:MZNPETF
|
$642.84 |
|
Empire Diversified Energy Inc
PINK:MPIR
|
$643.50 |
|
VN Index
VN:VNI
|
$643.53 |
|
Vidullanka PLC
CM:VLLN0000
|
$643.64 |
|
Unified Factory S.A.
WAR:UFC
|
$641.55 |
|
Sabaa International Company for Pharmaceutical and Chemical
EGX:SIPC
|
$640.12 |
|
FDES11F
SA:FDES11F
|
$638.83 |
|
Throgmorton Trust Plc
LSE:THRG
|
$638.50 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in NDT Pharmaceuticals Inc's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares NDT Pharmaceuticals Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently NDT Pharmaceuticals Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares NDT Pharmaceuticals Inc's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $59,082,939
- Average return on equity (ROE) among peers: -341.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| NDT Pharmaceuticals Inc (NDTP) | $- | N/A | N/A | $642.68 |
| Aadi Bioscience Inc (AADI) | $-124.24K | 0.00% | 0.00x | $17.03 Million |
| America Great Health (AAGH) | $-992.37K | 0.00% | 0.00x | $2.12 Million |
| Ascentage Pharma Group International (AAPG) | $70.63 Million | -1310.51% | 34.40x | $2.25 Billion |
| Aardvark Therapeutics, Inc. Common Stock (AARD) | $-27.92 Million | 0.00% | 0.00x | $59.18 Million |
| ABIVAX Société Anonyme (AAVXF) | $196.01 Million | -75.37% | 0.67x | $377.86 Million |
| Abcellera Biologics Inc (ABCL) | $10.25 Million | -21.57% | 1.29x | $738.02 Million |
| Abeona Therapeutics Inc (ABEO) | $489.00K | -1919.02% | 38.85x | $202.79 Million |
| Acumen Pharmaceuticals Inc (ABOS) | $188.78 Million | -22.70% | 0.04x | $108.65 Million |
| Abpro Holdings, Inc. (ABP) | $-22.46 Million | 0.00% | 0.00x | $2.00 Million |
| Absci Corp (ABSI) | $176.18 Million | -62.76% | 0.23x | $345.85 Million |